Feasibility of Home Instillation of UGN-102 for Treatment of Low-Grade (LG) Non-Muscle-Invasive Bladder Cancer (NMIBC)
Status:
Recruiting
Trial end date:
2022-06-01
Target enrollment:
Participant gender:
Summary
This study aims to demonstrate that home instillation of UGN-102 is a feasible alternative to
instillation in a clinical setting, which might mitigate some of the challenges in the
patient experience (logistical, expense, and comfort) when receiving treatment for low-grade
non-muscle-invasive bladder cancer at intermediate risk of recurrence (LG IR NMIBC).